<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Accumulating evidences indicate that dysregulated microRNAs (miRNA) are involved in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> <z:mp ids='MP_0002006'>tumorigenesis</z:mp> and progression </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study, we evaluated the expression of miR-182 in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and adjacent noncancerous tissues and explored its associations with clinicopathological characteristics and prognosis </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Quantitative real-time PCR was used to analyze the expression of miR-182 in 148 pairs of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and adjacent noncancerous tissues </plain></SENT>
<SENT sid="3" pm="."><plain>The relationship between miR-182 expression and clinicopathological characteristics in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissues was estimated using Mann-Whitney U test or Kruskal-Wallis test, as appropriate </plain></SENT>
<SENT sid="4" pm="."><plain>We calculated the survival curves and prognostic values of each variable by the Kaplan-Meier method and Cox proportional hazards regression analysis, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The expression of miR-182 was found up-regulated in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissues compared with adjacent noncancerous tissues (p &lt; 0.001), and its up-regulation was significantly correlated with large <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size (p = 0.016), positive regional lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (p = 0.008), and advanced <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-node-<z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> stage (p = 0.020) </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, Kaplan-Meier analysis demonstrated that high miR-182 expression predicted poor survival (p = 0.001), and Cox proportional hazards risk analysis indicated that miR-182 was an independent prognostic factor for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: MiR-182 was up-regulated in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissues and correlated with adverse clinical characteristics and poor prognosis, indicating that miR-182 might be involved in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> progression and could be used as a potential prognostic biomarker and therapeutic target in the management of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>